Clin2
NCT07746999Possibly a fitEnrolling by invitation

Liver health study for transgender adults

HEPATITIS C (HCV)

Part of Digestive system, Infections clinical trials.

This study looks at liver health in transgender individuals to better understand and improve care. You may join if you are 18 or older and can read and write in English.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are a transgender individual
  • You are 18 years old or older
  • You can read and write in English
  • You do not have decompensated liver cirrhosis

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT01644903Recruiting
Checking biomarkers after a liver transplant

This study follows people who are getting a liver transplant (including repeat transplants) to monitor changes in their body using test results. It may help doctors understand how patients are doing after transplant and improve care over time.

Chicago, Illinois
NCT00001971Recruiting
Evaluation of patients with liver disease

This research study evaluates people with liver disease or at risk for liver disease, and compares them with healthy volunteers. The goal is to better understand liver disease and improve how doctors diagnose and treat it.

Bethesda, Maryland
NCT07187947Recruiting
Heart health in transgender people on hormone therapy

This study looks at how gender-affirming hormone therapy affects the heart and blood vessels in transgender people. If you've been on hormones for at least a year, researchers want to check your cardiovascular health to better understand long-term risks and benefits.

Bologna, BO
NCT06245681Recruiting
How Hormone Therapy Affects the Heart and Liver

This study looks at how cross-sex hormone treatment affects the heart and fat in the liver. It aims to help understand the safety of hormone therapy in transgender individuals.

Vienna, State of Vienna
NCT07394400Not yet recruiting
Hormone therapy effects on health in transgender adults

This study looks at how gender-affirming hormone therapy affects heart, metabolic, and mental health in transgender adults. It may help us understand the benefits and risks of this treatment.

Valencia, Valencia
NCT05042544Recruiting
Testing program for people at risk of hepatitis C

This trial studies point-of-care (on-site) testing to find hepatitis C in adults who are at higher risk. If hepatitis C is found, earlier detection can help you get connected to care sooner.

Canberra, Australian Capital Territory

Hear when a new HEPATITIS C (HCV) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.